Advanced Search

 

Study ID Status Title Patient Level Data
202 Completed A Single-Dose Bioequivalence/Effect of Food Evaluation of WELLBUTRIN® Sustained-Release
202012 Completed PRJ2429: Effect of inhaled corticosteroid (ICS) particle size on asthma efficacy and safety outcomes: A systematic literature review and meta-analysis
202026 Not yet recruiting LAMICTAL Special Drug Use Investigation(mono-therapy for Typical Absence Seizure)
202029 Recruiting ZAGALLO Capsules Drug Use Investigation
202031 Terminated A double-blind (sponsor unblind), randomized, placebo-controlled, single and repeat escalating dose study to investigate the safety, tolerability, and pharmacokinetics of CCI15106 capsules for inhalation in healthy subjects and patients with moderate chronic obstructive pulmonary disease (COPD)
202050 Completed PGx7607: PGx evaluation of pyrexia by meta-analysis of melanoma subjects from BRF113710, BRF113929, BRF113683, MEK115306 and MEK116513
202051 Completed PGX7608: PGx evaluation of efficacy of dabrafenib and trametinib by meta-analysis of melanoma subjects from BRF113710, BRF113929, BRF113683, MEK114267, MEK115306 and MEK116513
202055 Completed European Medicines Agency (EMA) post-authorisation safety study of influenza vaccine
202063 Completed Additional subgroup analysis of onabotulinumtoxinA phase III trial in post-stroke patients with upper limb spasticity
202065 Completed Meta-Analysis Plan for an exploratory analysis of a composite endpoint for deterioration to compare the efficacy of Umeclidinium/Vilanterol Inhalation Powder 62.5/25 mcg with tiotropium 18mcg in subjects with Chronic Obstructive Pulmonary Disease (COPD)
202066 Completed Meta-Analysis Plan for an analysis to compare the efficacy of Umeclidinium/Vilanterol Inhalation Powder 62.5/25 mcg with tiotropium 18mcg in subjects with Chronic Obstructive Pulmonary Disease (COPD)
202067 Completed Meta-Analysis Plan for an analysis to compare the addition of Umeclidinium Inhalation Powder 62.5mcg to ICS/LABA with Placebo plus ICS/LABA in subjects with Chronic Obstructive Pulmonary Disease (COPD)
202089 Completed Predictive effect of eosinophil counts on bronchodilator response in COPD
202091 Completed Safety and immunogenicity study of GSK Biologicals’ investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (GSK3390107A) in adults in Africa
202093 Completed A Phase 2a Study to Evaluate the Pharmacokinetic, Safety, Tolerability and Clinical Effect of Topically Applied Umeclidinium/GSK573719 in Subjects with Primary Axillary Hyperhidrosis
202115 Completed Can social listening data be used to provide meaningful insights into potential abuse of bupropion?
202121 Completed PGx7635: Meta-analysis of data from FCGR PGx evaluations of ofatumumab DLBCL studies
202122 Completed PGx7597: Meta-analyses of data from FCGR PGx evaluations of ofatumumab CLL studies
202146 Not yet recruiting HO-15-15509 - Adelphi survey Benlysta effectiveness
202161 Completed A clinical study investigating the efficacy of a dentifrice in providing immediate and short term relief from dentinal hypersensitivity
202172 Terminated A Study to Assess Efficacy over Placebo and Speed of Onset of Pain Relief of new Paracetamol and caffeine tablets as Compared to Ibuprofen in Episodic Tension Type Headache
202175 Withdrawn Panadol Osteo PBS Claims Cohort Study
202177 Completed A Clinical Study to Assess the Efficacy of Pain Relief of Topical Indomethacin Patch over Placebo in Ankle Sprain Patients
202178 Completed A Magnetic Resonance Imaging Study of Nasal Strips in Subjects with Nasal Congestion
202179 Completed A Clinical Study to Assess the Efficacy and Onset of Pain Relief of Topical MFC51123 Diclofenac-Menthol Gel versus Controls in Ankle Sprain

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.